Anne L Escaron
Overview
Explore the profile of Anne L Escaron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nascimento de Lima P, Matrajt L, Coronado G, Escaron A, Rutter C
JAMA Netw Open
. 2025 Jan;
8(1):e2454938.
PMID: 39820690
Importance: Several noninvasive tests for colorectal cancer screening are available, but their effectiveness in settings with low adherence to screening and follow-up colonoscopy is not well documented. Objective: To assess...
2.
Coronado G, Nyongesa D, Petrik A, Thompson J, Escaron A, Pham T, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Feb;
33(4):525-533.
PMID: 38319289
Background: Mailed fecal immunochemical test (FIT) outreach can improve colorectal cancer screening participation. We assessed the reach and effectiveness of adding notifications to mailed FIT programs. Methods: We conducted secondary...
3.
Thompson J, Rivelli J, Escaron A, Garcia J, Ruiz E, Torres-Ozadali E, et al.
Hisp Health Care Int
. 2023 Nov;
22(4):216-224.
PMID: 37936370
Colorectal cancer (CRC) is a leading cause of cancer death in the US. Screening by fecal immunochemical test (FIT) is a strategy to lower CRC rates. Unfortunately, only half of...
4.
Coronado G, Anyane-Yeboa A, Byhoff E, Escaron A, Sonik R, Talamantes E, et al.
J Gen Intern Med
. 2023 Oct;
39(2):312-315.
PMID: 37884838
No abstract available.
5.
Coronado G, Nyongesa D, Escaron A, Petrik A, Thompson J, Smith D, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Aug;
32(11):1608-1616.
PMID: 37566431
Background: Mailed fecal immunochemical test (FIT) outreach can improve colorectal cancer screening rates, yet little is known about how to optimize these programs for effectiveness and cost. Methods: PROMPT was...
6.
Coronado G, Ruiz E, Torres-Ozadali E, Thompson J, Rivelli J, Thibault A, et al.
PLOS Digit Health
. 2023 May;
2(5):e0000258.
PMID: 37253020
No abstract available.
7.
Gautom P, Escaron A, Garcia J, Thompson J, Rivelli J, Ruiz E, et al.
BMC Gastroenterol
. 2023 May;
23(1):179.
PMID: 37221503
Introduction: In partnership with a federally qualified health center (FQHC), an adapted virtual version of boot camp translation (BCT) was used to elicit input from Spanish-speaking Latino patients and staff...
8.
Schneider J, Rivelli J, Vaughn K, Thompson J, Petrik A, Escaron A, et al.
Transl Behav Med
. 2023 May;
13(10):757-767.
PMID: 37210075
Colorectal cancer (CRC) is a leading cause of cancer death in the USA. Screening programs in federally qualified health centers (FQHCs) are essential to reducing CRC-related mortality and morbidity among...
9.
Escaron A, Garcia J, Petrik A, Ruiz E, Nyongesa D, Thompson J, et al.
J Prim Care Community Health
. 2022 Nov;
13:21501319221138423.
PMID: 36448466
Objective: Individuals with an abnormal fecal immunochemical test (FIT) result have an elevated risk of colorectal cancer, and the risk increases if the follow-up colonoscopy is delayed. Of note, rates...
10.
Davis M, Schneider J, Petrik A, Miech E, Younger B, Escaron A, et al.
Ann Fam Med
. 2022 Mar;
20(2):123-129.
PMID: 35346927
Purpose: Mailed fecal immunochemical test (FIT) programs can facilitate colorectal cancer (CRC) screening. We sought to identify modifiable, clinic-level factors that distinguish primary care clinics with higher vs lower FIT...